Status:
COMPLETED
Assessment of the Anti-inflammatory Effect of Heparin Infusion Versus Subcutaneous Injection in Septic Patients
Lead Sponsor:
Damanhour University
Conditions:
Sepsis
Critical Illness
Eligibility:
All Genders
18-64 years
Phase:
PHASE2
Brief Summary
Venous thromboembolism (VTE), including pulmonary embolism (PE) and deep venous thrombosis (DVT), is a common and severe complication of critical illness. Critically ill patients are at high risk of V...
Detailed Description
1. Ethical committee approval will be obtained from the Ethics Committee of the Faculty of Pharmacy, Damanhour University. 2. All participants or their next kin should agree to participate in this cli...
Eligibility Criteria
Inclusion
- Adults Patients aged 18 years old or greatecritically ill patients aged 18-65 years diagnosed with sepsis/septic shock or developed sepsis/septic shock during their ICU length of stay were enrolled.
Exclusion
- Thrombocytopenia, Intracerebral hemorrhage at the time of sepsis Bleeding tendency (INR ≥ 1.5 or PLT \< 50 x 109/L,) Medical condition requiring therapeutic anticoagulation Age \< 18 years Previous history of Heparin Induced Thrombocytopenia (HIT).
Key Trial Info
Start Date :
August 29 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 11 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04313790
Start Date
August 29 2020
End Date
October 11 2022
Last Update
July 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
amira Bisher kassem
Damanhūr Shubrā, Egypt, 22511